The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has established a Geriatric Expert Group, to provide scientific advice on issues related to the elderly.
The group’s mandate, objectives and rules of procedure explain that the group will contribute to the work of the CHMP and the Agency secretariat by:
- Giving input on guidelines under consultation
- Giving advice on geriatric aspects of the development, assessment or safety monitoring of medicines
- Taking part in meetings where expertise on geriatrics is needed
- Contributing to the geriatric implementation plan.
The group is formed of nine members with expertise in the scientific and regulatory aspects of geriatrics. It will meet virtually on an ad-hoc basis as required, communicating by e-mail, telephone conference or web conference only.
The establishment of the group forms a major step in the implementation of the Agency’s geriatric medicines strategy, adopted in February 2011 as part of the implementation of the Agency’s Road Map to 2015.